Default modetwork connectivity and its clinical relevance for depression in multiple sclerosis: A scoping review Authors: Laura Culicetto, Giulia Marafioti, Viviana Lo Buono, Giangaetano D’Aleo, Carmela Rifici, Edoardo Sessa, Angelo Quartarone, Silvia Marino Published: 2026 ABSTRACT BackgroundDepression is one of the most disabling neuropsychiatric manifestations of multiple sclerosis (MS), yet its neural mechanisms have received limited investigation. Growing evidence suggests that large-scale brain network dysfunction, particularly the default mode network (DMN), may play a key role in MS-related depression.ObjectiveThis scoping review aimed to synthesize the available evidence on the relationship between DMN resting-state functional connectivity and depressive symptoms in individuals with MS.MethodsA scoping review was conducted in accordance with PRISMA-ScR guidelines. PubMed, Scopus, Web of Science, and Embase were searched up to November 2025. Studies were included if they involved adults with MS, assessed depressive symptoms using validated measures, and examined DMN connectivity using resting-state fMRI.ResultsAcross the four included studies, consistent alterations of DMN connectivity were observed in relation to depressive symptoms in MS. These included posterior cingulate cortex hypoconnectivity, anterior cingulate cortex hyperconnectivity, and widespread hippocampal–DMN disconnection. DMN abnormalities were associated with depressive symptom severity and were only partially explained by lesion burden, brain atrophy, disability or cognitive status. Notably, aerobic exercise induced changes in DMN connectivity that paralleled reductions in depressive symptoms, suggesting that DMN dysfunction may be a modifiable target.ConclusionsConverging evidence indicates that depression in MS is linked to alterations in DMN functional organization, supporting a network-based model of MS-related depression rather than a purely reactive psychiatric interpretation. Although the current evidence is limited by small sample sizes and predominantly cross-sectional designs, these findings highlight the DMN as a promising neurobiological marker and potential therapeutic target. Introduction Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative condition of the central nervous system that affects more than 2.8 million individuals globally (Alexopoulos et al., 2002, Arnett, 2005). MS most often develops in young adulthood and follows a chronic course, markedly affecting quality of life (QoL), independence, and use of health-care resources (Compston and Coles, 2008). MS is traditionally categorized into four clinical phenotypes: clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), primary progressive MS (PPMS), and secondary progressive MS (SPMS) (Belleau et al., 2019). These phenotypes are defined by two key descriptors: (i) evidence of disease activity, such as clinical relapses or new MRI lesions, and (ii) worsening of disability over time (Belleau et al., 2019). In both research and clinical settings, these classifications and descriptors are routinely applied to determine patient eligibility for clinical trials and to inform therapeutic decision-making. MS lead to a diverse and often progressively disabling set of symptoms, including fatigue, impaired mobility, cognitive difficulties, and mental health disturbances (Belzung et al., 2015, Bisecco et al., 2018). Among these manifestations, depressive symptoms are particularly common, carry a substantial burden, and remain insufficiently treated in many individuals with MS (Biswal et al., 1995). Depression involves a reduction in positive affect, such as diminished interest or pleasure in activities, and an increase in negative affect, including feelings of sadness, hopelessness, or guilt (Bluhm et al., 2009). According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), depression encompasses several subtypes that can differ substantially in severity, such as major depressive disorder (MDD) and persistent depressive disorder (PDD). Many individuals with MS experience depressive symptoms without fully meeting DSM-5 diagnostic criteria for MDD or PDD. In fact, between 25% and 54% of people with MS report depressive symptoms, compared with approximately 22% in the general population (Bonavita et al., 2011). These symptoms collectively exert major negative impacts on QoL, employment, social relationships, and adherence to treatment in MS. Additionally, suicide risk in people with MS is estimated to be twice that of the general population (Bonavita et al., 2017). Resting-state (RS) functional MRI (fMRI) is a task-independent technique that enables an unbiased examination of the organization and integrity of brain functional networks by measuring spontaneous blood-oxygen-level-dependent (BOLD) signal fluctuations that arise when the brain is at rest (Broyd et al., 2009, Cao et al., 2012). The use of RS-fMRI has offered important insights into the pathophysiological mechanisms underlying numerous neurological and psychiatric disorders (Chen et al., 2015, Christodoulou et al., 2009, Chwastiak and Ehde, 2007). In MS, rs-fMRI has been primarily applied to investigate intrinsic functional architecture and connectivity, and how these relate to disease progression and clinical impairment (Compston and Coles, 2008, Cordes et al., 2000). Within this context, particular attention has been directed toward the intrinsic activity of the default mode network (DMN), a medial cortical system encompassing the precuneus and posterior cingulate cortex (PCC), the angular gyrus, the medial prefrontal cortex (mPFC), the hippocampus, and inferior parietal regions, which is characteristically active during rest and suppressed during goal-directed behaviors (Compston and Coles, 2008, Damoiseaux et al., 2012, Davidson et al., 2002). In individuals with major depressive disorder, abnormalities within the DMN have been consistently reported (Dunn et al., 2020, Faivre et al., 2012, Feinstein et al., 2004, Filippi et al., 2019) and associated with dysfunctional psychological processes characteristic of the condition, including altered self-referential thinking, cognitive distortions, ruminative tendencies, and shifts in processing style (from concrete to overly general) (Filippi et al., 2019). Moreover, disrupted RS functional connectivity between the hippocampus and frontal, temporal, and parietal regions has also been documented in these patients (Gold et al., 2010, Greicius, 2008, Greicius et al., 2007). Growing evidence indicates that resting-state functional connectivity of the DMN is altered in people with MS who experience depressive symptoms, suggesting a close link between mood disturbances and large-scale network dysfunction (Greicius et al., 2007, Greicius et al., 2007). Although depression frequently co-occurs with other neuropsychiatric manifestations in MS, it represents a distinct and highly prevalent clinical condition whose specific neural correlates are still largely unexplored. Importantly, the extent to which different levels of depressive symptom burden are associated with distinct patterns of DMN alteration has not yet been systematically clarified. On this basis, the present scoping review aims to comprehensively examine and synthesize the available evidence on the relationship between DMN functional connectivity and depressive symptoms in the MS population, in order to identify consistent neurofunctional patterns and highlight relevant gaps for future research. Materials and methods A scoping review was conducted to comprehensively examine and synthesize the available evidence on the relationship between DMN functional connectivity and depressive symptoms in individuals with MS. This review adhered to the PRISMA extension for scoping reviews (PRISMA-ScR) guidelines to ensure methodological rigor (Guo et al., 2013) and was registered on OSF (10.17605/OSF.IO/9TFNQ) in December 2025. PCC model The PCC framework (Population, Concept, and Context), as recommended by Pollock et al., (2023) was employed to construct clear and meaningful objectives and eligibility criteria for this scoping review: Population: Adults with MS (any phenotype: CIS, RRMS, PPMS, SPMS). Concept: Resting-state functional connectivity of the DMN in relation to depression or depressive symptoms in MS. This included studies assessing DMN alterations associated with depressive severity, depression-related mechanisms, or treatment-induced changes in depressive symptoms. Context: Studies conducted in clinical, research, or neuroimaging settings, with no restrictions regarding geographical location, health-care system, or cultural background. Search strategy A scoping review of currently published studies was performed in October 2025 using the following databases: Scopus, PubMed, Web of Science, and Embase. The search combined the following terms: ("multiple sclerosis"[All Fields] OR "MS"[All Fields]) AND ("depression"[All Fields] OR "depressive symptoms"[All Fields] OR "mood"[All Fields]) AND ("default mode network connectivity"[All Fields] OR "default mode network"[All Fields] OR "DMN"[All Fields] OR "resting state"[All Fields]). Inclusion and Exclusion Criteria The inclusion criteria were (i) adult people with MS; (ii) studies examining resting-state functional connectivity of the DMN and its relationship with depression; (iii) studies assessing depression using neuropsychological tests or clinical interviews; (iv) peer-reviewed articles published in English. We excluded (i) conference proceedings or commentary; (ii) review; (iii) letters to the editor, and (iv) gray literature such as conference proceedings, reports, and non-peer-reviewed literature. This exclusion was made to ensure methodological rigor by focusing on peer-reviewed articles, which are considered to offer a higher level of quality and reliability. Study selection To minimize bias and ensure a rigorous selection process, two authors (L.C. and G.M.) independently screened the titles and abstracts of the studies based on the inclusion and exclusion criteria. Any discrepancies were resolved through collaborative discussion, with consultation from a third author (V.L.B). This multi-step approach ensured that at least three researchers independently assessed each article. The final inclusion or exclusion decision was based on predefined criteria regarding population, concept, and context (e.g., healthcare or rehabilitation settings). In cases of persistent disagreement, the final decision involved all authors. Data extraction and analysis The studies that met the inclusion criteria were summarized based on the following points: (1) study characteristics, including the type of study and the country where the data were collected; (2) patient characteristics, such as the sample size, age, gender, duration of disease, and the level of education; and (3) key findings and relevant outcomes. Following the full-text selection, data were extracted from the included studies and reported in a table using Microsoft Excel (Version 2021). The extracted data included study title, first author name, year of publication, study aims and design, sample size, type of participants, type of intervention and control, baseline performance, type of outcome and time-points for assessment, results, and key conclusions. Moreover, the agreement between the two reviewers (L.C. and G.M.) was assessed using the kappa statistic. The kappa score, with an accepted threshold for substantial agreement set at > 0.61, was interpreted to reflect substantial concordance between the reviewers. This criterion ensures a robust evaluation of the inter-rater reliability, ensuring a high level of agreement in the data extraction process. Results The study selection process adhered to the PRISMA-ScR guidelines and is summarized in Fig. 1. Of the 992 studies initially identified through database searches, 648 remained after the duplicate removal. Following the title and abstract screening, 61 studies were assessed for eligibility based on their full text. Ultimately, 4 studies were included in the review, meeting all predefined eligibility criteria. This small number likely reflects both the limited availability of studies on this specific topic and the focused eligibility criteria adopted to ensure conceptual and methodological consistency.Fig. 1Search and selection of eligible articles. Search and selection of eligible articles. Key findings Across the four included studies, consistent evidence indicates that alterations in the DMN constitute a central neural correlate of depressive symptoms in MS (Table 1).Table 1Main characteristics of the included studies.AuthorsStudy designPopulationEmotional assessmentMRI / fMRI methodsMain resultsBonavita et al., (2017)Cross-sectional observational studyD-MS: 16 subjects (M/F 4/12) age 38.1 ± 9.4;ND-MS: 17 subjects (M/F: 4/13) age 41.9 ± 8.3;ND-HC: 17 subjects (M/F: 5/2) age 39.2± 15.3D-S: 15 subjects (M/F: 4/11) age 40.8 ±8.5.CMDIResting-state fMRI; ICA of DMN, SN, ECNDepressed MS patients showed reduced PCC connectivity and increased ACC connectivity within the DMN, a pattern distinct from both non-depressed MS patients and depressed healthy controls. These changes could not be attributed to gray-matter atrophy or lesion burden.Høgestøl et al., (2019)Cross-sectional observational studyRRMS subjects 74 (M/F 22/52) (67 usable scans); age 35.5 ± 9.4BDIResting-state fMRI; DMN seed connectivity; PCA of symptomsDepressive symptoms were associated with symptom-specific DMN alterations. Combined depression–fatigue burden was linked to DMN hyperconnectivity, whereas depression with minimal fatigue corresponded to reduced DMN connectivity.Iosipchuk et al., (2025)Randomized controlled trial (aerobic exercise vs stretching)MS: 10 ambulatory subjects (M/F = 4/6); age ≈ 52 (SD n/a)IG:Intervention group: 5 MS subjects; age 45.4 ± 9.9HC: 5 subjects; age 47.8 ± 14.0.BDI–Fast Screen (BDI-FS)Resting-state fMRI; DMN connectivity with vmPFC seedAerobic exercise led to reductions in depressive symptoms accompanied by increases in DMN connectivity. After training, higher DMN connectivity predicted lower depressive symptoms in the exercise group, whereas in controls it was associated with worse mood.Rocca et al., (2015)Cross-sectional observational study69 MS subjects (M/F: 33/36) age 37.5 ± 9.4 and 42 HC (M/F: 20/22) age 36.4 ± 11.1MADRSResting-state fMRI with hippocampal seeds; structural MRI for lesion loadMS patients showed widespread reductions in hippocampal–DMN connectivity. The degree of disconnectivity was strongly related to T2 lesion load, and depressive severity correlated with reduced hippocampal connectivity to core DMN regions including the precuneus and orbitofrontal cortex.Legend: MS = Multiple Sclerosis;Depressed MS (D-MS); Non-depressed MS (ND-MS); Healthy controls non-depressed (ND-HC); Depressed subjects (D-S, senza MS) RRMS = Relapsing–Remitting Multiple Sclerosis;CMDI = Chicago Multiscale Depression Inventory; BDI / BDI-FS = Beck Depression Inventory / Fast Screen; MADRS = Montgomery–Åsberg Depression Rating Scale; DMN = Default Mode Network; SN = Salience Network; ECN = Executive Control Network; ICA = Independent Component Analysis; vmPFC = Ventromedial Prefrontal Cortex; rs-fMRI = Resting-state Functional MRI; HC = Healthy Controls; PCC = Posterior Cingulate Cortex; ACC = Anterior Cingulate Cortex Table 1Main characteristics of the included studies.AuthorsStudy designPopulationEmotional assessmentMRI / fMRI methodsMain resultsBonavita et al., (2017)Cross-sectional observational studyD-MS: 16 subjects (M/F 4/12) age 38.1 ± 9.4;ND-MS: 17 subjects (M/F: 4/13) age 41.9 ± 8.3;ND-HC: 17 subjects (M/F: 5/2) age 39.2± 15.3D-S: 15 subjects (M/F: 4/11) age 40.8 ±8.5.CMDIResting-state fMRI; ICA of DMN, SN, ECNDepressed MS patients showed reduced PCC connectivity and increased ACC connectivity within the DMN, a pattern distinct from both non-depressed MS patients and depressed healthy controls. These changes could not be attributed to gray-matter atrophy or lesion burden.Høgestøl et al., (2019)Cross-sectional observational studyRRMS subjects 74 (M/F 22/52) (67 usable scans); age 35.5 ± 9.4BDIResting-state fMRI; DMN seed connectivity; PCA of symptomsDepressive symptoms were associated with symptom-specific DMN alterations. Combined depression–fatigue burden was linked to DMN hyperconnectivity, whereas depression with minimal fatigue corresponded to reduced DMN connectivity.Iosipchuk et al., (2025)Randomized controlled trial (aerobic exercise vs stretching)MS: 10 ambulatory subjects (M/F = 4/6); age ≈ 52 (SD n/a)IG:Intervention group: 5 MS subjects; age 45.4 ± 9.9HC: 5 subjects; age 47.8 ± 14.0.BDI–Fast Screen (BDI-FS)Resting-state fMRI; DMN connectivity with vmPFC seedAerobic exercise led to reductions in depressive symptoms accompanied by increases in DMN connectivity. After training, higher DMN connectivity predicted lower depressive symptoms in the exercise group, whereas in controls it was associated with worse mood.Rocca et al., (2015)Cross-sectional observational study69 MS subjects (M/F: 33/36) age 37.5 ± 9.4 and 42 HC (M/F: 20/22) age 36.4 ± 11.1MADRSResting-state fMRI with hippocampal seeds; structural MRI for lesion loadMS patients showed widespread reductions in hippocampal–DMN connectivity. The degree of disconnectivity was strongly related to T2 lesion load, and depressive severity correlated with reduced hippocampal connectivity to core DMN regions including the precuneus and orbitofrontal cortex.Legend: MS = Multiple Sclerosis;Depressed MS (D-MS); Non-depressed MS (ND-MS); Healthy controls non-depressed (ND-HC); Depressed subjects (D-S, senza MS) RRMS = Relapsing–Remitting Multiple Sclerosis;CMDI = Chicago Multiscale Depression Inventory; BDI / BDI-FS = Beck Depression Inventory / Fast Screen; MADRS = Montgomery–Åsberg Depression Rating Scale; DMN = Default Mode Network; SN = Salience Network; ECN = Executive Control Network; ICA = Independent Component Analysis; vmPFC = Ventromedial Prefrontal Cortex; rs-fMRI = Resting-state Functional MRI; HC = Healthy Controls; PCC = Posterior Cingulate Cortex; ACC = Anterior Cingulate Cortex Main characteristics of the included studies. Legend: MS = Multiple Sclerosis;Depressed MS (D-MS); Non-depressed MS (ND-MS); Healthy controls non-depressed (ND-HC); Depressed subjects (D-S, senza MS) RRMS = Relapsing–Remitting Multiple Sclerosis;CMDI = Chicago Multiscale Depression Inventory; BDI / BDI-FS = Beck Depression Inventory / Fast Screen; MADRS = Montgomery–Åsberg Depression Rating Scale; DMN = Default Mode Network; SN = Salience Network; ECN = Executive Control Network; ICA = Independent Component Analysis; vmPFC = Ventromedial Prefrontal Cortex; rs-fMRI = Resting-state Functional MRI; HC = Healthy Controls; PCC = Posterior Cingulate Cortex; ACC = Anterior Cingulate Cortex In the cross-sectional rs-fMRI study by Høgestøl et al. (Iosipchuk et al., 2025) involving 74 recently diagnosed RRMS people (67 with usable imaging), the authors examined how fatigue and depression jointly influence intrinsic DMN connectivity. By applying principal component analysis to Fatigue Severity Scale (FSS) and Beck Depression Inventory (BDI) scores, they identified symptom dimensions that mapped onto distinct patterns of network behavior. A higher combined burden of depression and fatigue was associated with DMN hyperconnectivity, whereas depression occurring with minimal fatigue corresponded to reduced DMN connectivity. Fatigue alone also showed a positive association with DMN connectivity, while depression alone did not. These findings remained robust after accounting for lesion volume, whole brain and cortical atrophy, cognitive performance, and disability, suggesting that different depressive–fatigue profiles recruit the DMN in divergent ways. A similar emphasis on the DMN emerged in the randomized controlled trial analyzed by Iosipchuk et al. (Kaiser et al., 2015), which included 10 ambulatory MS subjects randomized to either 12 weeks of aerobic treadmill training or stretching control activities. Although designed to address memory impairment, the trial allowed for a secondary investigation into depression and resting-state connectivity. Participants undergoing aerobic exercise exhibited clear reductions in depressive symptoms compared with minimal or negative change in controls, and these clinical improvements were mirrored by meaningful shifts in DMN connectivity. Notably, after the intervention, higher DMN connectivity, particularly within ventromedial prefrontal regions, predicted lower depressive symptom severity in the exercise group, whereas the same pattern predicted higher depressive symptoms in controls. This inversion of the connectivity–symptom relationship suggests that aerobic exercise may influence DMN functioning in parallel with improvements in depressive symptoms. However, given the exploratory nature of the study and the limited number of longitudinal data available, the DMN should be considered a potential correlate or mediator candidate rather than an established mechanism. The role of DMN dysregulation in MS-related depression was further underscored by the observational study of Bonavita et al. (Greicius et al., 2007), which compared depressed and non-depressed MS patients with both depressed and non-depressed healthy controls. This work revealed a distinct pattern of DMN disruption in MS patients with depression, one that could not be explained by gray matter atrophy or lesion burden. In particular, depressed MS patients demonstrated a substantial reduction in posterior cingulate cortex (PCC) connectivity, a key DMN hub typically preserved or even hyperconnected in non-depressed MS subjects. Conversely, they also showed increased anterior cingulate cortex (ACC) connectivity, a feature commonly associated with primary depressive disorders. These opposing DMN abnormalities closely tracked depressive severity, and because PCC hypoconnectivity is also implicated in cognitive decline, the authors highlighted a potential shared DMN-based mechanism linking mood disturbances and cognitive dysfunction in MS. The largest sample among the studies, reported by Rocca et al. (Greicius et al., 2007), included 69 cognitively preserved MS patients and 42 healthy controls and focused specifically on hippocampal connectivity, given the hippocampus’ integral role within the DMN and its vulnerability in both MS and major depressive disorder. Using seed-based rs-fMRI, the authors demonstrated widespread reductions in hippocampal–DMN functional coupling across frontal, parietal, temporal, and cingulate regions. Importantly, the magnitude of this disconnectivity correlated strongly with T2 lesion load, indicating that structural white matter damage likely disrupts DMN–hippocampal integration. Depressive symptom severity, measured via Montgomery-asberg depression rating scale (MADRS), was associated with reduced hippocampal connectivity to key DMN components including the precuneus and orbitofrontal cortex, regions implicated in affect regulation and self-referential processing. Longer disease duration and greater disability further predicted reduced connectivity, suggesting that progressive hippocampal–DMN disintegration contributes not only to depression but also to broader clinical deterioration. Taken together, these studies converge on the conclusion that DMN dysconnectivity, whether expressed through PCC hypoconnectivity, ACC hyperconnectivity, hippocampal disconnection, or symptom-dependent hyper/hypoconnectivity, plays a central role in the emergence and modulation of depressive symptoms in MS. The DMN appears sensitive to structural damage, symptom profiles, and behavioral interventions, reinforcing its importance as a mechanistic target for understanding and treating depression in the MS population. Discussion Across the examined literature, converging evidence highlights the DMN as a central neural substrate linking depressive symptomatology and MS. Although depression in MS is highly prevalent and frequently under-recognized, its biological mechanisms have been only partially explored. Resting-state fMRI studies provide an important window onto large-scale intrinsic network dysfunction, and collectively the four studies included in this review offer substantial insight into how DMN alterations may contribute to mood disturbances in MS. However, given the predominance of cross-sectional designs, these findings should not be interpreted as evidence of a causal role of DMN dysfunction in the development of depressive symptoms. Across the studies examined in this review, the relationship between depression and functional connectivity (FC) alterations in MS emerges as a multifaceted phenomenon that extends well beyond the notion of depression as a merely co-occurring psychiatric condition. The consistently higher annual prevalence of depression in MS compared with both healthy individuals and other chronic medical conditions (Kalb et al., 2019) has led many authors to argue that affective symptoms may represent an intrinsic component of the disease. This perspective has stimulated extensive efforts to identify the structural and functional brain substrates that might underpin depressive symptoms in people with MS. Structural neuroimaging research has documented several abnormalities associated with depression in MS, including increased T2 lesion load in the left arcuate fasciculus, right frontal lesions, and temporal atrophy (Kilpatrick et al., 2022), as well as reduced normal-appearing white matter in the left superior frontal region, greater T1 lesion burden in the right medial inferior frontal cortex, elevated diffusivity in the anterior temporal lobe, and diminished fractional anisotropy in adjacent white matter (Lublin, 2014). Further evidence from Gold et al. (McFadden et al., 2013) suggests that depression in MS may be linked to specific patterns of hippocampal atrophy, particularly involving the CA2–3/dentate gyrus. Yet, many of these structural studies did not systematically assess cognitive status nor include matched healthy controls and depressed individuals without MS, limiting the ability to isolate MS-specific substrates of depression. In major depressive disorder, converging evidence indicates that depressive symptoms arise from dysfunction within distributed neural networks rather than isolated regional disturbances (McFadden et al., 2013, McFadden et al., 2013). Against this backdrop, resting-state fMRI (RS-fMRI) has increasingly been used to investigate large-scale functional networks. Altered connectivity has been repeatedly demonstrated in major depression within the salience network (SN), executive control network (ECN), and, most prominently, the DMN (Mesaros et al., 2008). The DMN, encompassing the anterior cingulate cortex (ACC), posterior cingulate and precuneus (PCC/PCN), and inferior parietal cortices (IPC) (Patten et al., 2003), plays a central role in intrinsic cognition and mood regulation and shows robust abnormalities in depressed individuals (Penner and Paul, 2017, Pollock et al., 2023). The studies included in this review adopted this network-based perspective to examine whether similar alterations characterize depression in MS. When functional connectivity was compared across depressed MS patients (D-MS), non-depressed MS patients (ND-MS), depressed subjects without MS (D-S), and healthy controls (ND-HC), distinct patterns emerged that appear to reflect the combined influence of MS pathology and depressive mechanisms. For instance, ND-MS patients displayed the well-described pattern of reduced ACC connectivity—likely attributable to MS-related disease effects—and increased lateral PCC connectivity, interpreted as a compensatory reorganization supporting preserved cognition (Chen et al., 2015, Prinster et al., 2006). This compensatory interpretation is consistent with evidence showing that cognitively preserved MS patients exhibit enhanced PCC connectivity relative to cognitively impaired individuals (Prinster et al., 2006) The most informative contrasts for understanding MS-related depression involved comparisons between D-MS and the other three groups. When D-MS were compared to D-S, no significant differences emerged in the anterior DMN node, the ACC, whereas a clear reduction appeared in the PCC. In contrast, when D-MS were compared to ND-MS, depression was associated with increased ACC connectivity alongside reduced PCC connectivity. These findings may reflect two opposing influences acting on the ACC: MS pathology tends to decrease ACC connectivity, while depression, as observed in major depressive disorder, tends to increase it. When both influences coexist, their effects may obscure one another, explaining why D-MS and D-S did not differ in ACC connectivity. Only when contrasted with ND-MS does the net effect of depression within the context of MS become visible as ACC hyperconnectivity. The functional complexity of the ACC may further illuminate these findings. The ACC comprises at least two subdivisions—affective and cognitive (Pujol et al., 1997), with distinct connectivity profiles linking it to limbic, paralimbic, parietal, and prefrontal structures. Dysfunction within these interconnected frontal circuits has been linked to late-life depression (Raichle et al., 2001), and the “depression–executive dysfunction” syndrome described by Alexopoulos et al. (Rocca et al., 2015) shares conceptual features with abnormalities seen in MS. Given that MS lesions frequently disrupt frontal white-matter pathways, it is plausible that MS subjects are inherently at heightened risk of developing depressive symptoms due to compromised functioning of these same circuits. This interpretation is reinforced by evidence that similar network disruptions are present in cognitively impaired MS patients (Chen et al., 2015), supporting a possible shared network vulnerability underlying both depression and cognitive decline. The consistent reduction of PCC connectivity in D-MS patients also deserves emphasis. Although diminished PCC FC is well established in cognitively impaired MS subjects (Prinster et al., 2006), its presence among cognitively preserved depressed individuals suggests a deeper connection between mood disturbances and early network alterations. This idea is compatible with findings from cross-sectional studies showing associations between depressed mood and cognitive dysfunction in MS (Rocca et al., 2010) and with longitudinal evidence indicating that mood scores can predict future cognitive decline (Rocca et al., 2012). Together, these observations support the hypothesis of a functional link between depressive and cognitive symptoms mediated by posterior DMN vulnerability. Beyond the DMN, studies also identified alterations within the SN and ECN. Increased FC in regions such as the left middle frontal gyrus in ND-MS patients likely reflects disease-related effects, whereas heightened FC in right supramarginal and middle frontal gyri in D-MS patients may represent depression-related changes superimposed on MS pathology. Patterns within the ECN proved more difficult to disentangle, with some connectivity increases attributable to disease effects and others potentially reflecting depressive symptoms. Prior literature reports both increased (Roosendaal et al., 2010) and decreased (Sandroff et al., 2018) FC in these networks in MS, and increased FC has often been interpreted as compensatory reorganization during early or less advanced disease stages (Sandroff et al., 2021). Given that the patients described in these studies were cognitively preserved with low disability scores, it is reasonable to hypothesize that some FC increases represent adaptive processes still active at this stage of the disease. Finally, although gray-matter atrophy was found in MS subjects compared with controls (Sandroff et al., 2021, Sbardella et al., 2015), these structural differences did not co-localize with the regions showing functional changes. The absence of voxel-based morphometry differences between D-MS and ND-MS or between ND-HC and D-S groups indicates that the RS-fMRI alterations identified cannot be attributed to underlying regional GM atrophy. This reinforces the idea that functional disconnection—rather than structural degeneration alone—plays a central role in shaping depressive symptomatology in MS. In the study by Høgestøl et al., (Iosipchuk et al., 2025), multivariate decomposition revealed significant associations between depressive symptoms and DMN connectivity. The main symptom component incorporating depression showed a positive correlation with DMN FC, consistent with prior findings of DMN hyperconnectivity in depressed individuals (Mesaros et al., 2008). The observed relationship aligns with earlier evidence suggesting a functional link between depression and cognitive impairment in MS (Greicius et al., 2007), and parallels findings in Alzheimer’s disease (AD), where depression has been proposed to reflect neurodegenerative processes rather than secondary emotional consequences (Shu et al., 2014). Taken together, these results support the hypothesis that depressive symptoms in MS are tied to alterations in intrinsic network organization, potentially reflecting disrupted information integration within the DMN. A second component, representing a pattern of high depressive symptoms independent of fatigue, showed a negative correlation with DMN connectivity. This indicates that depression in MS may manifest through reduced DMN connectivity in certain conditions, echoing studies demonstrating that specific DMN regions show distinct FC abnormalities depending on the clinical phenotype (Siegert, 2005). These findings reinforce the notion that depression in MS is heterogeneous and may arise from different profiles of network disruption, with DMN alterations reflecting the broader variability of symptom expression in the disease (Staff et al., 2009). Importantly, the associations between depressive symptoms and DMN connectivity remained largely unchanged after adjusting for disability, cognitive performance, disease-modifying treatment (DMT) level, brain volume, cortical thickness, and lesion burden. Although lower global brain volume was associated with higher depressive scores, structural adjustments did not substantially alter the connectivity patterns. This suggests that DMN dysfunction linked to depression may arise from functional disconnection mechanisms rather than localized atrophy alone. With regard to the neural mechanisms underlying exercise-driven improvements in depression among people with MS, the study by Iosipchuk et al., (Kaiser et al., 2015) indicates that aerobic exercise may alleviate depressive symptoms by altering resting-state functional connectivity within the DMN. After 12 weeks of supervised treadmill training, increases in DMN connectivity were strongly associated with reductions in depressive symptoms, an effect not observed in the control group. This finding aligns with previous work linking DMN connectivity to both the presence and modulation of depressive symptoms in the general population (Sundgren et al., 2013, Taylor et al., 2003, Trapp and Nave, 2008, Tricco et al., 2018). Since the DMN functions as a core hub for integrating external sensory inputs with intrinsic cognitive processes, its adaptation in response to the multisensory, physiologically demanding nature of aerobic exercise may represent a mechanism through which physical activity exerts mood-enhancing effects in MS (Walton et al., 2020). These results parallel earlier evidence showing exercise-related DMN changes in both healthy individuals and persons with MS (Wise et al., 2017, Wittayanukorn et al., 2014). Altogether, the findings suggest that targeting DMN connectivity through structured physical activity may be a promising avenue for future interventions aimed at reducing depression in MS. Taken together, this body of evidence indicates that depression in MS is closely linked to alterations of DMN functional organization, reflecting a complex interaction between disease-related disconnection processes and mood-specific network dysfunction. These findings support a network-based interpretation of depressive symptoms in MS rather than a purely reactive or secondary psychiatric model. Nevertheless, the current evidence remains insufficient to determine whether DMN abnormalities represent a cause, a consequence, or a concomitant neural correlate of depressive symptoms in MS. From a clinical perspective, this has important implications, as it suggests that interventions capable of modulating large-scale brain networks, particularly the DMN, may contribute to the management of depression in MS. In this context, growing evidence supports the role of structured physical exercise and rehabilitative interventions as promising, non-pharmacological strategies capable of inducing beneficial DMN plasticity and reducing depressive symptom burden (Walton et al., 2020, Wittayanukorn et al., 2014, Zeng et al., 2012). Clinicians should therefore consider incorporating network-informed approaches into comprehensive rehabilitation programs for people with MS, with the aim of improving both emotional well-being and overall QoL. Limitations and future directions The findings synthesized in this review should be interpreted within the context of several limitations shared across the included studies. First, all investigations were based on relatively small and clinically homogeneous samples, typically newly diagnosed or mildly affected RRMS patients with preserved cognition and low disability, which constrains the generalizability of the results to individuals with progressive MS or more severe neuropsychiatric involvement. This is particularly evident in the study by Iosipchuk et al., (Kaiser et al., 2015), where the exploratory nature and small sample size (10 people) severely limit statistical power and the robustness of conclusions. Furthermore, depressive symptoms were consistently assessed using self-report questionnaires such as the BDI or MADRS rather than structured clinical interviews, making it difficult to differentiate between subthreshold affective distress and clinically defined depressive disorders. In the study by Høgestøl et al. (Iosipchuk et al., 2025), the absence of a healthy control group further limits the ability to determine whether the observed associations between depression and DMN connectivity are specific to MS. A second major limitation concerns the predominance of cross-sectional or retrospective designs, which prevents establishing causal relationships between DMN alterations and depressive symptoms. While functional connectivity abnormalities were consistently identified, the underlying structural correlates were not always thoroughly addressed. Some studies controlled for lesion burden or brain volume, yet microstructural damage, demyelination, and diffuse tissue loss—factors known to contribute to disconnection syndromes in MS (Sandroff et al., 2018, Zeng et al., 2012) were not systematically evaluated. The study by Bonavita et al. (Greicius et al., 2007) showed that structural differences did not co-localize with functional abnormalities, but this also underscores the need for multimodal approaches combining rs-fMRI with more sensitive measures of white- and gray-matter integrity. Another recurring issue relates to sample characteristics: in Høgestøl et al. (Iosipchuk et al., 2025), both fatigue and depressive symptoms were relatively mild compared with larger MS populations (Zeng et al., 2012), and the same applied to depressive severity in Rocca et al. and Bonavita et al., where most patients exhibited mild mood symptoms. This raises the possibility that more pronounced DMN alterations might emerge in patients with moderate or severe depression. Moreover, several studies excluded individuals with fatigue or cognitive impairment, limiting ecological validity and overlooking the frequent co-occurrence of these symptoms with depression in MS. Despite evidence suggesting that DMN connectivity may change with interventions such as aerobic exercise (Walton et al., 2020, Zhou et al., 2020, Zhu et al., 2012), current findings remain preliminary, and no study provided long-term follow-up to establish the durability of such effects. The lack of healthy controls in some investigations also prevents determining whether exercise-related DMN modulation is specific to MS or reflects general neuroplastic mechanisms. Taken together, these limitations highlight the need for future research employing larger and more diverse samples, rigorous diagnostic procedures for depression, longitudinal designs, and multimodal neuroimaging capable of capturing both functional and structural network alterations. Greater attention should also be given to interactions between the DMN and other networks implicated in depression, such as the SN and ECN (Mesaros et al., 2008). Finally, future randomized controlled trials specifically designed to test whether modifying DMN connectivity can reduce depressive symptoms in MS may help clarify whether the DMN represents a viable mechanistic and therapeutic target. Conclusion Across the available literature, a consistent pattern emerges indicating that depressive symptoms in MS are closely associated with disruption of the DMN. Alterations in DMN functional connectivity, involving anterior, posterior, and hippocampal nodes, appear to represent a core neural signature of depressive symptoms in MS and are only partially explained by structural damage, disability, or cognitive impairment. These findings support the view that depression in MS reflects a functional disconnection process superimposed on disease-related vulnerability, rather than a purely reactive psychiatric condition. Importantly, emerging evidence suggests that the DMN may represent both a marker of depressive symptomatology and a potentially modifiable therapeutic target. Behavioral interventions, particularly structured physical exercise, may induce beneficial changes in DMN connectivity that parallel clinical improvements in mood, pointing to the potential of network-oriented rehabilitation strategies. Nevertheless, the current body of evidence remains limited by small sample sizes, restricted clinical phenotypes, and a predominance of cross-sectional designs. Future research should therefore focus on larger, heterogeneous MS populations, longitudinal approaches, and multimodal imaging in order to clarify causal mechanisms and identify interventions capable of effectively modulating DMN dysfunction. Overall, these findings reinforce the need to conceptualize depression in MS as a disorder of large-scale brain network organization. A deeper understanding of DMN involvement may promote earlier identification of vulnerable individuals and support the development of targeted, network-informed treatment strategies aimed at improving both emotional well-being and QoL in people with MS. Funding This study was supported by Current Research Funds 2026, RRC-2026–23688274 Ministry of Health, Italy. CRediT authorship contribution statement Viviana Lo Buono: Writing – review & editing, Visualization, Validation, Supervision. Giulia Marafioti: Writing – review & editing, Writing – original draft, Validation, Investigation. Culicetto Laura: Writing – review & editing, Writing – original draft, Validation, Resources, Project administration, Methodology, Investigation, Formal analysis, Data curation, Conceptualization. Edoardo Sessa: Writing – review & editing, Visualization, Validation. Carmela Rifici: Writing – review & editing, Visualization, Validation. Giangaetano D’Aleo: Writing – review & editing, Visualization, Validation. Silvia Marino: Writing – review & editing, Visualization, Validation, Supervision, Project administration, Investigation. Angelo Quartarone: Visualization, Validation, Resources, Funding acquisition. Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.